Preliminary study of the stability of dexamethasone when added to commercial veterinary ear cleaners over a 90 day period

Background Topical corticosteroids are commonly used in the management of allergic otitis externa to diminish inflammation. A common strategy is to make compounded solutions of dexamethasone in ear cleaner. Hypothesis/Objectives The objective of this study was to determine the stability of dexamethasone when added to four commercial ear cleaners (ec): designated ecA, ecB, ecC and ecD. Methods and Materials Two concentrations (0.1 and 0.25 mg/mL) of dexamethasone were formulated for each cleaner solution from a 2 mg/mL solution and stored in the original manufacturers’ bottles at two temperatures: room (22 ˚C) and refrigerated (4 ˚C). Samples were evaluated in triplicate, using liquid chromatography‐tandem mass spectrometry at 10 time points over 90 days. The mean and standard deviation were calculated for each time point. Results A solution was considered stable if the dexamethasone value remained >90% of the target concentration. All dexamethasone solution values were stable to 90 days, except two solutions for ecA; the 0.25 mg/mL dexamethasone concentration was only stable to 14 (4 ˚C) and 21 days (22 ˚C). Conclusions and clinical importance These results provide preliminary evidence in support of pharmaceutical stability data for dexamethasone when included in the above compounded solutions at the noted concentrations and temperatures. Stability of dexamethasone over time and at different temperatures when compounded with Triz‐ULTRA + KETO Flush ear cleaner. Triz‐ULTRA + KETO Flush ear cleaner with 0.25 mg/mL (2 mg/mL) dexamethasone is only stable until Day 21 at room temperature (22 ˚C) and until Day 14 at refrigerator temperature (4 ˚C). RÉSUMÉ Contexte Les corticoïdes topiques sont fréquemment utilisés dans la gestion des otites chroniques externes pour diminuer l’inflammation. Une stratégie fréquente consiste à réaliser des préparations composées de déxaméthasone dans une solution de nettoyage. Hypothèses/Objectifs L’objectif de cette étude a été de déterminer la stabilité de déxaméthasone quand ajoutée à quatre solutions de nettoyant auriculaire commerciales (ec) : ecA, ecB, ecC et ecD. Matériel et méthodes Deux concentrations (0,1 et 0,25 mg/mL) de déxaméthasone ont été formulées pour chaque solution nettoyante à partir d’une solution de 2 mg/mL et conservées dans les bouteilles du fabricant à deux températures : ambiante (22°)et réfrigérée (4°C). Les échantillons ont été évalués en triple, à l’aide de spectrométrie de masse en chromatographie liq